z-logo
Premium
Determination of a novel diacylglycerol acyltransferase 1 inhibitor, 2‐[4‐(4‐{5‐[2‐phenyl‐5‐(trifluoromethyl) oxazole‐4‐carboxamido]‐1H‐benzo[d]imidazol‐2‐yl} phenyl) cyclohexyl] acetic acid (KR‐69232) in rat plasma using liquid chromatography–tandem mass spectrometry and its application to a pharmacokinetic study
Author(s) -
Seo Hyewon,
Choi Sung Heum,
Kwak EunYoung,
Zheng Zhi,
Kwak Hyun Jung,
Ahn Jin Hee,
Lee YongMoon,
Ahn SungHoon,
Bae Myung Ae,
Song Jin Sook
Publication year - 2014
Publication title -
biomedical chromatography
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.4
H-Index - 65
eISSN - 1099-0801
pISSN - 0269-3879
DOI - 10.1002/bmc.3053
Subject(s) - chemistry , oxazole , trifluoromethyl , chromatography , acetic acid , pharmacokinetics , stereochemistry , organic chemistry , pharmacology , medicine , alkyl
A liquid chromatography–tandem mass spectrometry method was developed and validated for the quantification of KR‐69232, a diacyltransferase 1 inhibitor, in rat plasma. KR‐69232 in the concentration range of 0.004–4 µg/mL was linear. The intra‐and inter‐day precision and accuracy were acceptable (<20%). KR‐69232 was stable under various storage and handling conditions. The method was applied successfully in a pharmacokinetic study of KR‐69232 in rats. Copyright © 2013 John Wiley & Sons, Ltd.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom